Soohyeon Lee
Cheonan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Development of a multivariable prediction model for tumor response and treatment tolerance based on body composition dynamics in rectal cancer undergoing neoadjuvant chemoradiotherapy.
Journal: Journal of gastrointestinal oncology
Published: March 14, 2026
Functional characterization of BRCA2 variants of uncertain significance identified in Korean breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: January 16, 2026
A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04).
Journal: Scientific reports
Published: December 19, 2025
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancers.
Journal: International journal of clinical oncology
Published: December 04, 2025
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 01, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: August 29, 2025
Comparative immunohistochemical expression of TROP2 in brain metastatic and primary tumors.
Journal: American journal of cancer research
Published: August 08, 2025
Mechanistic Insights into Radiation Resistance in Colorectal Cancer: Gene Exploration Study.
Journal: International journal of molecular sciences
Published: March 14, 2025
Clinicopathologic Analysis of Five Patients with POLE-Mutated Colorectal Cancer in a Single Korean Institute.
Journal: Diagnostics (Basel, Switzerland)
Published: March 13, 2025
MCC in the spotlight: Its dual role in signal regulation and oncogenesis.
Journal: Cellular signalling
Published: January 24, 2025
Gut microbiome with RAS mutation and chemotherapy response in patients with advanced or metastatic colorectal cancer: a pilot, exploratory study.
Journal: Frontiers in oncology
Published: January 23, 2025
Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial.
Journal: Cancer communications (London, England)
Published: December 17, 2024
Last Updated: 09/26/2026